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Introduction 
Nucleic acids are essential molecules that are characteristic of life on the earth. It stores and 
transfers hereditary information from one generation to next. Nucleic acids are basically 
divided into deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) as genetic material 
and it is involved in several biological processes like transcription, translation, gene storage. 
(Wang et al., 2016) The protection and conservation of genetic material are very crucial 
process and it preserves the cell from external damage. (Rodriguez et al., 2008). There are the 
number of proteins that involved in translation and replication of DNA. The small molecules 
which are mimicking this protein are modulating the DNA structure by binding with the 
DNA and inhibiting the replication process, sometime it may cause cell death. Hence the 
molecule targeting to nucleic acids play an important role as anticancer and antiviral. 
Therefore it is an important issue in recent year. (Shaikh et al., 2004)   
 Several Strategies have been devised for serving that purpose and revelation of "DNA/RNA 
targeting novel small molecules" remains a promising one. Till date, incessant research 
efforts have created such a pool of drugs and probable drug candidates with vivid poly 
functionalized basic scaffolds like quinoxaline. Quinoxaline and its related derivatives show 
various pharmacological and other relative bio-activities  like antiproliferative (Montana et 
al., 2014; Desplat et al., 2010; Weng et al., 2011), antimicrobial  (Henen et al., 2011; Vieira 
et al., 2014; Ishikawa et al., 2012 ),  antiviral, (Waring et al., 2002; Wilhelmsson et al., 2008; 
Zeifman et al., 2014; Summa et al., 2012; Henen et al., 2011).  
 
Statement of problem 
Our idea of using monoquinoxaline moiety as a novel scaffold for targeting nucleic acid  
surfaced from the discovery of DNA interacting antitumor quinoxaline antibiotic such as 
Echinomycin. The structural template of the antibiotic includes two bicyclic chromophores 
(quinoxaline) connected across a dimerized cyclic peptide linker (Waring et.al 1974) i.e. 
depsipeptide. The structural complexity of this antibiotic and time consuming synthetic 
strategy motivated us towards the design and synthesis of monoquinoxaline based derivatives 
targeting nucleic acid. In our present research work we successfully designed and synthesised 
monoquinoxaline based small molecule targeting double stranded DNA (chapter 2). 
Subsequently we also derivatized the monoquinoxaline moiety with different functional 
groups and targeted towards HCV IRES (chapter 3). The modification of quinoxaline to 
dihydropyrimido fused quinoxaline ring system give rise  to fluorescent analogue (chapter 4).  
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Methodology and Results  
In second chapter part 2A we showed, design and synthesis of  2,3 diamino derivatives of 
monoquinoxaline compound with benzyl substituent (3d, 3e, 3f ) act as intercalator followed 
by DNA conformational change in sigmoidal fashion. (Mahata et al., 2016) The design of 
quinoxaline derivatives was inspired by the structure  of the dsDNA-bound quinoxaline 
antibiotic triostin A (Figure 1A)  and the monoquinoxaline derivatives reported by Waring et 
al. The scaffold contained a triply substituted (C2, C3, and C6) monoquinoxaline (Figure 1B) 
with the C6-nitro group as a synthetic handle for C2/C3 substitutions, the C2/C3 quinoxaline 
amines as potential DNA hydrogen-bond donors, and the C3 propyl dimethyl amine for 
electrostatic interactions with DNA and to facilitate a snug fit in the minor-groove (alkyl 
chain). The C2-quinoxaline amine was substituted with various groups ranging from small 
and simple alkyl groups to bulky aromatic moieties (Mahata et al., 2016).In quinoxaline 
antibiotics, diquinoxaline part of quinoxaline antibiotic (trostin A) help in the major grove 
interaction and peptide part help in the minor grove interaction , the design monoquinoxaline 
derivative the C2 part help in the minor grove interaction and C3 part help in the major grove 
interaction. On the other hand non benzyl based diaminoquinoxaline did not show 
intercalation property (Angew. Chem. Int.  Ed.2016,55, 7733 –7736). 
 
 Figure 1: Design of quinoxaline based small molecule targeting deoxyribonucleic acid 
We also suggest a model (Figure 2) where we shown how 3d molecule interact with DNA 
and 3d aggregate associated structural change in DNA, this model is supported by our DLS 
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and docking data. On the other hand non benzylated substituent not able to do intercalation 
associated subsequent event. Finally we conclude that benzyl substituted based  quinoxaline 
derivatives excellent starting material for DNA based intercalator. 
 
Figure 2 : A) As shown in picture firstly 3d interact with DNA in non -intercalative mode followed by intercalation event by 
3d molecule A to B. C) Intercalation induced association of 3d aggregate with DNA bound 3d molecule B to  C causing 
structural change in DNA. 
However, without extensive and systematic changes of the benzyl group it was not clear 
whether aromatic stacking interactions or generic hydrophobic interactions are responsible 
for the observed sigmoidal binding.  
In chapter 2B we showed Hydrophobicity of benzyl substituent is another factor that is 
associated with conformational change and condensation of DNA. Herein we have 
investigated DNA binding of 3d (Figure 1) variants that contain various substituents on the 
benzyl moiety. Several analogues of 3d were synthesized, where the benzylic moiety was 
replaced with  4-aminobenzyl, 4-bromobenzyl , 4-fluorobenzyl , 4-trifluoro methyl benzyl , 4 
chloro benzyl  and N-4-tolylpent-4-ynamide. 
We also replaced the phenyl ring by pyridine and furan  to study the effect of a 
heteroatom in the aromatic domain. We studied the interaction of benzyl varient from 
hydrophilic to hydrophobic with DNA by various biophysical techniques to probe the effect 
of DNA intercalation and DNA conformational change by varying the benzyl substituents of 
3d. Unwinding of supercoiled plasmid DNA upon DNA intercalation was tested by agarose 
gel shift assay. Circular dichroism studies of calf thymus DNA (ct DNA) with the compounds 
were performed to characterize the DNA binding mode and DNA conformational change. We 
further performed EtBr (a known DNA intercalator) displacement assays to complement the 
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gel shift assay and CD studies. On the basis observations we conclude that hydrophobic 
interactions between the benzyl substituent are the main influence behind DNA-binding 
induced conformational change. The implication of stacking interactions was testified using 
two substituents, pyridine and furan. Interestingly, none of them showed the characteristic 
DNA-binding signature, indicating stacking interactions might play a secondary role. This 
manuscript work is  under preparation. 
After successfully designed and synthesised benzyl substituent based small quinoxaline 
molecule targeting DNA, our next goal was designed and synthesis of  quinoxaline based 
small molecule targeting IRES of hepatitis C virus. 
In third chapter we showed the design and synthesis of  quinoxaline based small 
molecule targeting IRES (Internal Ribosomal Entry Site) of hepatitis C virus. As from 
literature study it is well known  fact that hepatitis C is highly contagious disease. It is 
estimated that millions of people have been diagnosed with this viral infection all over world 
and most of them are in chronic condition. In HCV genome most of conserve region is 5' and 
3' untranslated region. The 5' region has an internal ribosomal entry site (IRES) and  
compound directed at IRES may surely benefit due to its unique and high sequence conserved 
structural domains and role in viral translation .  
Design of monoquinoxaline based small molecule targeting IRES of HCV is based on 
crystal structure of subdomain IIa RNA inhibitor complex (Figure 3 section A ) (Dibrov et 
al.). In crystal structure it shows that the benzimidazole  part of ligand 1(Figure 3 section D) 
help in stacking interaction with A53 and G52-C111. 2- amino and ring nitrogen  form the 
Hoogsteen base pair with C58-G110 (Figure 3 section B). There is additional hydrogen bond 
formation of  protonated  N,N dimethyl propyl amine side chain interaction with phosphate 
back bone of A109 (Figure 3 section B). On the basis of crystal structure we designed 
monoquinoxaline based small molecule (Figure 3 section C), where we hypothesize that  
quinoxaline part help in stacking interaction with A53 and G52-C111. Quinoxaline and ring 
nitrogen might help in forming Hoogsteen base pair with C58-G110. Protonated N,N 
dimethyl propyl amine side chain would interact with phosphate back bone of A109. Here we 
were systematically changed the substituent's on second, third, sixth position of quinoxaline. 
The selected synthesised derivatives were showed significant inhibition of IRES mediated 
translation process which were analysed by dual luciferase assay. This work manuscript is 
also under preparation. 
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Figure 3:  A) Crystal structure of subdomain IIa RNA inhibitor  complex (Dibrov et al., 2013) B) Imidazole and 2- amino 
nitrogen of ligand 1 forming Hoogsteen base pair with C58-G110 (Dibrov et al., 2013)  C) Designing of monoquinoxaline 
based small molecule based on crystal structure of subdomain IIa RNA inhibitor complex D) Structure of ligand 1. 
Cellular imaging with fluorescent molecules is an important field and currently 
different fluorescent dyes are developed and marketed for their extensive use in the 
biomedical applications. We are also interested in development of fluorescent molecules with 
large stokes shift which can target biological macromolecules and can be imaged inside cells 
but  2,3 di-amino derivatives of benzylated monoquinoxaline compounds are non fluorescent, 
so our next goal is convert it into fluorescent analogues. In chapter four we showed novel 
reaction between 2,3 diamino derivatives of benzylated monoquinoxaline and ditertiary butyl 
acetylene dicarboxylate afforded fluorescent analogue (dihydropyrimido quinoxaline). 
Synthesis of dihydropyrimidoquinoxaline involves sp3 C–N bond cleavage mechanism,  
which is not shown earlier with Quinoxaline compounds. We have also shown by laser 
confocal microscopy that live cell imaging of HepG2 cells can be performed with 
dihydropyrimidoquinoxaline compound and it is somewhere reside in cytoplasm of cell 
(Figure  4). (Kanungo et al., 2015). Further work with this scaffold derivatives is going on 
our lab and some of the derivatives of dihydropyrimidiquinoxaline  have potential to target t-
RNA with high fluorescent property. Extension work with dihydropyrimidoquinoxaline 
derivatives manuscript is under preparation.  
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Figure 4: Fluorescent image of live HepG2 cells after incubation with 4f. (A) Brightfield, (B) 1hr. with 4f (50 
nM), (C) DIC merged. Excitation and emission wavelength for 4f was at 405 nm and 542 nm respectively. 
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